SONX Stock Price, Sonendo, Inc. Quote, Chart

Market Summary

USD0.100.00

Delayed

0.00%

SONX Stock Price

View Fullscreen

SONX RSI Chart

SONX Valuation

Market Cap

6.7M

Price/Earnings (Trailing)

-0.11

Price/Sales (Trailing)

0.15

EV/EBITDA

-0.1

Price/Free Cashflow

-0.14

SONX Price/Sales (Trailing)

SONX Profitability

Operating Margin

24.44%

EBT Margin

-138.87%

Return on Equity

-214.36%

Return on Assets

-77.94%

Free Cashflow Yield

-703.68%

SONX Fundamentals

SONX Revenue

Revenue (TTM)

43.9M

Rev. Growth (Yr)

-4.4%

Rev. Growth (Qtr)

12.36%

SONX Earnings

Earnings (TTM)

-60.9M

Earnings Growth (Yr)

-0.24%

Earnings Growth (Qtr)

35.94%

Breaking Down SONX Revenue

Last 7 days

11.1%

Last 90 days

-28.6%

Trailing 12 Months

-92%

How does SONX drawdown profile look like?

SONX Financial Health

Current Ratio

1.85

Debt/Equity

0.44

Debt/Cashflow

-3.69

SONX Investor Care

Shares Dilution (1Y)

9.09%

Diluted EPS (TTM)

-0.65

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	43.3M	43.8M	44.4M	43.9M
2022	34.8M	37.4M	39.3M	41.7M
2021	25.8M	28.3M	30.7M	33.2M
2020	0	0	0	23.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Sonendo, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 03, 2024	chen roy t	sold	-70.434	0.091	-774	chief talent officer
May 03, 2024	bergheim bjarne	sold	-216	0.091	-2,381	president and ceo
Apr 15, 2024	guo chris	sold	-39.442	0.082	-481	interim cfo
Mar 26, 2024	chen roy t	sold	-273	0.1043	-2,625	chief talent officer
Mar 26, 2024	bergheim bjarne	sold	-1,198	0.1043	-11,493	president and ceo
Mar 15, 2024	bergheim bjarne	sold	-2,258	0.0967	-23,351	president and ceo
Mar 15, 2024	chen roy t	sold	-518	0.0967	-5,359	chief talent officer
Mar 15, 2024	pudipeddi vamsi mohan raj	bought	80,000	0.1	800,000	-
Mar 15, 2024	watts michael patrick	sold	-1,031	0.0967	-10,670	chief financial officer
Feb 05, 2024	chen roy t	sold	-111	0.151	-740	chief talent officer

Which funds bought or sold SONX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 11, 2024	VANGUARD GROUP INC	sold off	-100	-1,510,740	-	-%
Feb 14, 2024	Royal Bank of Canada	sold off	-100	-	-	-%
Feb 14, 2024	MASTERS CAPITAL MANAGEMENT LLC	added	185	-255,150	1,050,000	0.04%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	sold off	-100	-135,363	-	-%
Feb 14, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-219,601	-	-%
Feb 14, 2024	Redmile Group, LLC	sold off	-100	-306,071	-	-%
Feb 14, 2024	ArrowMark Colorado Holdings LLC	sold off	-100	-4,365,030	-	-%
Feb 14, 2024	Granite Investment Partners, LLC	new	-	11,970	11,970	-%
Feb 14, 2024	BOOTHBAY FUND MANAGEMENT, LLC	sold off	-100	-138,047	-	-%

Are Funds Buying or Selling SONX?

Are funds buying SONX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SONX

No. of Funds

Unveiling Sonendo, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	first light asset management, llc	9.98%	5,446,491	SC 13G/A
Feb 14, 2024	pura vida investments, llc	9.99%	5,422,384	SC 13G/A
Feb 14, 2024	driehaus capital management llc	4.85%	2,630,750	SC 13G/A
Feb 14, 2024	masters capital management llc	9.2%	5e+06	SC 13G
Nov 13, 2023	arrowmark colorado holdings llc	3.93%	2,068,411	SC 13G/A
Mar 16, 2023	jmr capital ltd	973%	3,021,605	SC 13G
Mar 03, 2023	bergheim olav	4.2%	2,112,325	SC 13G/A
Feb 14, 2023	orbimed advisors llc	0%	0	SC 13G/A
Feb 14, 2023	pura vida investments, llc	9.99%	4,976,591	SC 13G/A
Feb 14, 2023	first light asset management, llc	9.99%	5,067,338	SC 13G/A

Recent SEC filings of Sonendo, Inc.

View All Filings

Date Filed	Form Type	Document
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
Apr 29, 2024	ARS	ARS
Apr 29, 2024	DEF 14A	DEF 14A
Apr 29, 2024	DEFA14A	DEFA14A
Apr 18, 2024	PRE 14A	PRE 14A
Apr 16, 2024	4	Insider Trading
Apr 15, 2024	8-K	Current Report
Apr 11, 2024	25-NSE	25-NSE
Apr 10, 2024	8-K	Current Report

Peers (Alternatives to Sonendo, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	183.8B	40.3B	-5.00%	-5.05%	32.67	4.56	-2.84%	-3.08%
BDX	68.4B	19.7B	-3.90%	-6.73%	51.29	3.47	4.82%	-17.56%
ALGN	21.6B	3.9B	-9.51%	-8.38%	46.8	5.52	5.72%	46.72%
BAX	18.6B	14.9B	-14.34%	-20.72%	7.02	1.25	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	5.17%	22.48%	31.57	2.79	6.16%	35.06%
HSIC	8.8B	12.3B	-5.50%	-14.07%	21.17	0.71	-2.44%	-22.68%
BIO	8.2B	2.7B	-13.13%	-26.81%	-12.92	3.08	-4.68%	82.43%
XRAY	5.9B	3.9B	-12.57%	-31.60%	-62.73	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.38%	28.89%	-216.43	8.91	30.82%	65.57%
PDCO	2.3B	6.6B	-1.94%	-3.23%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.4B	3.2B	1.24%	-9.09%	-2.08	0.44	7.73%	-1066.14%
ANIK	413.1M	166.7M	8.74%	7.69%	-5	2.48	6.67%	-456.34%
ANGO	248.3M	324.0M	-11.81%	-28.90%	-1.29	0.77	-3.19%	-337.41%
APYX	48.5M	52.3M	-5.33%	-58.72%	-2.59	0.93	17.61%	19.28%
AEMD	3.4M	3.7M	-24.57%	300.00%	-0.28	0.92	5.77%	8.23%

Sonendo, Inc. News

Latest updates

Sonendo, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Revenue	12.4%	11,692,000	10,406,000	11,043,000	10,724,000	12,230,000	9,846,000	10,547,000	9,033,000	9,891,000	7,887,000	7,992,000	7,427,000	6,779,500	6,132,000
Cost Of Revenue	-1.3%	7,860,000	7,960,000	-	-	-	7,528,000	-	-	-	-	-	-	-	-
Gross Profit	56.7%	3,832,000	2,446,000	1,098,000	3,346,000	3,330,000	2,318,000	2,553,000	2,279,000	2,452,000	2,049,000	2,093,000	1,742,000	-	1,201,000
Operating Expenses	-26.0%	13,714,000	18,542,000	18,049,000	18,160,000	18,093,000	16,914,000	16,840,000	16,835,000	16,020,000	13,147,000	11,991,000	11,584,000	-	10,752,000
S&GA Expenses	-17.0%	11,163,000	13,442,000	14,751,000	14,666,000	14,513,000	12,586,000	12,822,000	11,985,000	11,513,000	8,495,000	7,381,000	6,524,000	-	5,802,000
R&D Expenses	-17.5%	2,514,000	3,049,000	3,298,000	3,494,000	3,580,000	4,328,000	4,018,000	4,850,000	4,258,000	4,633,000	4,631,000	5,046,000	-	4,920,000
EBITDA Margin	-1.4%	-1.23	-1.21	-1.21	-1.18	-1.25	-1.40	-1.41	-1.39	-1.31	-1.34	-1.45	-1.59	-1.76	-
Interest Expenses	0.2%	1,494,000	1,491,000	1,441,000	1,387,000	1,256,000	1,098,000	858,000	848,000	868,000	868,000	859,000	850,000	-	-
Earnings Before Taxes	35.9%	-10,876,000	-16,980,000	-17,690,000	-15,371,000	-10,850,000	-15,539,000	-15,137,000	-15,522,000	-13,709,000	-12,733,000	-11,149,000	-10,906,000	-	-10,593,000
EBT Margin	-1.3%	-1.39	-1.37	-1.36	-1.31	-1.37	-1.52	-1.53	-1.53	-1.46	-1.52	-1.65	-1.81	-2.00	-
Net Income	35.9%	-10,878,000	-16,980,000	-17,690,000	-15,371,000	-10,852,000	-15,539,000	-15,137,000	-15,522,000	-13,711,000	-12,733,000	-11,149,000	-10,906,000	-12,527,000	-10,593,000
Net Income Margin	-1.3%	-1.39	-1.37	-1.36	-1.31	-1.37	-1.52	-1.53	-1.53	-1.46	-1.54	-1.60	-1.73	-2.00	-
Free Cashflow	8.5%	-9,548,000	-10,432,000	-9,758,000	-17,210,000	-14,571,000	-15,560,000	-14,196,000	-18,101,000	-14,878,000	-10,270,000	-10,954,000	-13,141,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet											(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4
Assets	-11.5%	78.00	88.00	104	124	137	143	88.00	99.00	115	43.00	76.00
Current Assets	-13.5%	65.00	75.00	87.00	106	121	127	72.00	83.00	99.00	26.00	59.00
Cash Equivalents	15.9%	14.00	12.00	13.00	13.00	18.00	69.00	18.00	66.00	85.00	14.00	52.00
Inventory	-3.2%	11.00	11.00	13.00	16.00	15.00	15.00	13.00	10.00	8.00	7.00	4.00
Net PPE	207.4%	1.00	0.00	3.00	3.00	3.00	3.00	3.00	2.00	2.00	3.00	3.00
Goodwill	0%	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00
Liabilities	-1.6%	50.00	51.00	51.00	55.00	55.00	53.00	43.00	41.00	43.00	49.00	49.00
Current Liabilities	219.6%	35.00	11.00	11.00	15.00	17.00	14.00	14.00	12.00	15.00	13.00	41.00
Long Term Debt	-66.5%	12.00	37.00	37.00	37.00	37.00	37.00	27.00	27.00	26.00	26.00	-
LT Debt, Current	-	25.00	-	-	-	-	-	-	-	-	-	28.00
LT Debt, Non Current	-66.5%	12.00	37.00	37.00	37.00	37.00	37.00	27.00	27.00	26.00	26.00	-
Shareholder's Equity	-24.8%	28.00	38.00	53.00	69.00	82.00	90.00	45.00	58.00	72.00	-	-
Retained Earnings	-2.6%	-430	-419	-402	-384	-369	-358	-342	-327	-312	-298	-263
Additional Paid-In Capital	0.3%	458	457	455	453	451	449	388	386	384	11.00	10.00
Shares Outstanding	20.0%	64.00	53.00	53.00	51.00	50.00	29.00	26.00	26.00	26.00	1.00	1.00
Float	-	-	-	57.00	-	-	-	40.00	120	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	8.1%	-9,462	-10,300	-9,324	-16,976	-14,246	-15,323	-13,458	-18,045	-14,725	-10,015	-10,798	-13,067	-	-
Share Based Compensation	-16.4%	1,491	1,784	2,059	1,942	2,411	1,723	1,954	1,394	924	541	413	494	-	-
Cashflow From Investing	16.1%	11,423	9,839	9,175	11,965	-36,434	-2,946	-34,993	-56.00	-191	-255	-1,453	-74.00	-	-
Cashflow From Financing	101.0%	1.00	-100	109	-6.00	-167	69,183	-5.00	-486	85,809	-1,711	44.00	-645	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SONX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total revenue	$ 43,865	$ 41,656
Cost of sales, product and software	31,559	31,176
Impairment of long-lived assets	1,584
Total cost of sales	33,143	31,176
Gross profit	10,722	10,480
Operating expenses:
Selling, general and administrative	54,022	51,906
Research and development	12,355	16,776
Impairment of long-lived assets	2,088
Total operating expenses	68,465	68,682
Loss from operations	(57,743)	(58,202)
Interest and financing cost, net	(3,174)	(3,228)
Employee retention credit		4,382
Loss before income tax expense	(60,917)	(57,048)
Income tax expense	(2)	(2)
Net loss and comprehensive loss	(60,919)	(57,050)
Other comprehensive income (loss) (net of tax):
Unrealized gain (loss) on short-term investments	72	(61)
Comprehensive loss	$ (60,847)	$ (57,111)
Net loss per share - basic	$ (0.65)	$ (1.27)
Net loss per share - diluted	$ (0.65)	$ (1.27)
Weighted-average shares outstanding - basic	93,988,749	44,932,952
Weighted-average shares outstanding - diluted	93,988,749	44,932,952
Product
Total revenue	$ 34,628	$ 33,280
Cost of sales, product and software	28,375	28,193
Impairment of long-lived assets	1,584
Total cost of sales	29,959	28,193
Gross profit	4,669	5,087
Operating expenses:
Selling, general and administrative	51,639	49,859
Research and development	10,207	15,002
Impairment of long-lived assets	2,088
Total operating expenses	63,934	64,861
Loss from operations	(59,265)	(59,774)
Software
Total revenue	9,237	8,376
Cost of sales, product and software	3,184	2,983
Total cost of sales	3,184	2,983
Gross profit	6,053	5,393
Operating expenses:
Selling, general and administrative	2,383	2,047
Research and development	2,148	1,774
Total operating expenses	4,531	3,821
Loss from operations	$ 1,522	$ 1,572

SONX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 14,009	$ 17,665
Short-term investments	32,773	73,784
Accounts receivable, net	5,081	5,798
Inventory	11,074	15,462
Prepaid expenses and other current assets	2,334	8,397
Total current assets	65,271	121,106
Property and equipment, net	664	2,860
Operating lease right-of-use assets	2,974	2,455
Intangible assets, net	661	2,292
Goodwill	8,454	8,454
Other assets	136	118
Total assets	78,160	137,285
Current liabilities:
Accounts payable	1,176	4,438
Accrued expenses	3,266	5,357
Accrued compensation	2,758	3,616
Operating lease liabilities	1,377	1,114
Current portion of term loan	24,900
Other current liabilities	1,844	2,191
Total current liabilities	35,321	16,716
Operating lease liabilities, net of current	1,423	1,095
Term loan, net of current	12,467	36,746
Other liabilities	530	773
Total liabilities	49,741	55,330
Commitments and contingencies (Note 8)
Stockholders, equity:
Preferred stock, $0.001 par value; authorized - 10,000,000 shares; issued and outstanding - none
Common stock, $0.001 par value; authorized - 500,000,000 shares as of December 31, 2023 and 2022; issued - 63,547,467 shares as of December 31, 2023 and 49,974,281 shares as of December 31, 2022; outstanding - 63,547,467 shares as of December 31, 2023 and 49,974,281 shares as of December 31, 2022	64	50
Additional paid-in-capital	458,357	451,060
Accumulated other comprehensive gain (loss)	11	(61)
Accumulated deficit	(430,013)	(369,094)
Total stockholders' equity	28,419	81,955
Total liabilities and stockholders' equity	$ 78,160	$ 137,285

About Sonendo, Inc.

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

CEO	Mr. Bjarne Bergheim
WEBSITE	https://sonendo.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	244

Sonendo, Inc. Frequently Asked Questions

What is the ticker symbol for Sonendo, Inc.? What does SONX stand for in stocks?

SONX is the stock ticker symbol of Sonendo, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sonendo, Inc. (SONX)?

As of Mon May 06 2024, market cap of Sonendo, Inc. is 6.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SONX stock?

You can check SONX's fair value in chart for subscribers.

What is the fair value of SONX stock?

You can check SONX's fair value in chart for subscribers. The fair value of Sonendo, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Sonendo, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SONX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Sonendo, Inc. a good stock to buy?

The fair value guage provides a quick view whether SONX is over valued or under valued. Whether Sonendo, Inc. is cheap or expensive depends on the assumptions which impact Sonendo, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SONX.

What is Sonendo, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon May 06 2024, SONX's PE ratio (Price to Earnings) is -0.11 and Price to Sales (PS) ratio is 0.15. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SONX PE ratio will change depending on the future growth rate expectations of investors.